Icro Maremmani Selected Research

Heroin (Diamorphine)

10/2021	Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up.
1/2019	What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.
1/2018	The long-term outcome of patients with heroin use disorder/dual disorder (chronic psychosis) after admission to enhanced methadone maintenance.
1/2018	Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
1/2017	Opposed effects of hyperthymic and cyclothymic temperament in substance use disorder (heroin- or alcohol-dependent patients).
1/2016	The impact of psychopathological subtypes on retention rate of patients with substance use disorder entering residential therapeutic community treatment.
1/2016	Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug?
1/2016	The newer Opioid Agonist Treatment with lower substitutive opiate doses is associated with better toxicology outcome than the older Harm Reduction Treatment.
1/2016	Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates.
7/2015	Chronology of illness in dual diagnosis heroin addicts: The role of mood disorders.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Icro Maremmani Research Topics

Disease

14	Substance-Related Disorders (Drug Abuse) 01/2021 - 07/2007
13	Heroin Dependence (Heroin Abuse) 01/2018 - 02/2008
12	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 08/2006
9	Alcoholism (Alcohol Abuse) 11/2021 - 01/2009
8	Mental Disorders (Mental Disorder) 01/2019 - 01/2008
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2019
7	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 08/2006
6	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 02/2008
5	Mood Disorders (Mood Disorder) 01/2019 - 02/2010
5	Bipolar Disorder (Manic Depressive Psychosis) 01/2015 - 02/2008
4	Medically Unexplained Symptoms 01/2018 - 01/2011
3	Anxiety Disorders (Anxiety Disorder) 05/2021 - 04/2011
2	Personality Disorders (Personality Disorder) 01/2019 - 10/2009
2	Infections 12/2017 - 01/2017
2	Torsades de Pointes (Torsade de Pointes) 06/2013 - 01/2005
2	Mania (Manias) 09/2012 - 02/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Chronic Pain 01/2021
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2021
1	Hiccup (Hiccups) 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Gambling (Pathological Gambling) 01/2018
1	Reinfection 01/2017
1	Hepatitis C 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Erectile Dysfunction 01/2016
1	Major Depressive Disorder (Major Depressive Disorders) 12/2014
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2014
1	Obesity 02/2014
1	Cardiac Arrhythmias (Arrythmia) 06/2013
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 06/2013
1	Schizophrenia (Dementia Praecox) 04/2011
1	Pain (Aches) 03/2010
1	Cyclothymic Disorder 02/2008
1	Psychomotor Agitation (Akathisia) 11/2007

Drug/Important Bio-Agent (IBA)

25	Heroin (Diamorphine)IBA 10/2021 - 08/2006
15	Opioid Analgesics (Opioids)IBA 10/2021 - 01/2007
15	Methadone (Dolophine)FDA LinkGeneric 01/2019 - 01/2005
11	Cocaine (Cocaine HCl)IBA 01/2022 - 08/2006
6	Pharmaceutical PreparationsIBA 01/2019 - 11/2010
4	Buprenorphine (Subutex)FDA LinkGeneric 12/2017 - 07/2007
3	CannabinoidsIBA 01/2022 - 02/2010
3	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 11/2021 - 04/2016
3	Antidepressive Agents (Antidepressants)IBA 05/2021 - 01/2019
3	Opiate AlkaloidsIBA 01/2016 - 03/2014
2	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 11/2020
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 01/2019
2	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 01/2016
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2019 - 01/2007
2	nalmefene (Revex)FDA Link 01/2017 - 04/2016
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2014 - 02/2010
2	3,4-methylenedioxyethamphetamine (MDEA)IBA 02/2014 - 01/2011
2	AmphetaminesIBA 09/2012 - 02/2010
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Aripiprazole (Abilify)FDA Link 01/2021
1	Illicit Drugs (Recreational Drugs)IBA 01/2021
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Methylphenidate (Ritalin)FDA LinkGeneric 10/2019
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 10/2019
1	BenzodiazepinesIBA 01/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2017
1	InterferonsIBA 01/2017
1	Nicotine FDA Link 10/2016
1	ProlactinIBA 01/2016
1	Acamprosate (Campral)FDA Link 12/2014
1	Ethanol (Ethyl Alcohol)IBA 12/2014
1	Glutamic Acid (Glutamate)FDA Link 12/2014
1	Coffee FDA Link 09/2011
1	SolutionsIBA 05/2011
1	ropinirole (Requip)FDA LinkGeneric 01/2011
1	4-hydroxybutyric acidIBA 01/2009
1	Potassium Channels (Potassium Channel)IBA 01/2005

Therapy/Procedure

6	Self Medication 10/2019 - 04/2011
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2017
2	Therapeutics 12/2017 - 11/2010
2	Opiate Substitution Treatment 01/2016 - 01/2016